keyboard_arrow_up

In-Vitro Diagnostic (IVD) Market Expected to Reach $64 Billion by 2016

The report “In-Vitro Diagnostic (IVD) Market (Applications, End-users & Types) Trends & Global Forecasts (Major & Emerging Markets – G7, Japan & BRIC) (2011 - 2016)”, the global IVD market was valued at $44 billion in the year 2011, growing at a CAGR of 7.8% from 2011 to 2016. The U.S. represented the biggest market for the IVD equipments accounting for a share of 47% of the total IVD market in the year 2011.


Browse market data tables and in-depth TOC on “In-Vitro Diagnostic (IVD) Market”.

http://www.marketsandmarkets.com/Market-Reports/in-vitro-diagnostics-ivd-market-547.html

Early buyers will receive 10% customization on this report.

 

The European region accounted for 31% of the global IVD market with Germany accounting for the largest share of 23.24% followed France (16.89%) and Italy (16.41%) of the total IVD market.

 

The Asian region is dominated by Japan having the largest market in terms of value. However, due to the recent economic recession, the market of Japan has shown a stable growth with an average CAGR of 11.3%. The Asian region is expected to be ruled by the emerging economies such as China and India, show the highest CAGR by the year 2016. The Chinese IVD market is taking frog leap amongst the emerging nations, followed by India, Russia, and Brazil. The major driving factor for the IVD industry to boom in the emerging countries is the government funding and improved healthcare facilities.

 

Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=547

 

However, the condition is completely reverse in the developed countries such as North America and Eu-5 as these countries are facing major financial crisis and thus having deep cuts on the healthcare budgets with limited reimbursements provided on the clinical testing and the newly introduced tests in the market thus hampering the growth of IVD industry.

 

The laboratory testing market accounts for the highest market by end-user segmentation with a share of 73% with a market of $35.52 billion for the year 2011 and is expected to reach the market of $45.54 billion by the year 2016 with a CAGR of 6.9%.

 

Analyzers are the main instruments used for conducting the tests. The instruments account only major share of the market share of the IVD market, by types. The analyzers are of 3-types namely, high through put analyzers, medium throughput analyzers, and low throughput analyzers.

 

Talk To Our Research Analysts for More Information:

http://www.marketsandmarkets.com/speaktoanalyst.asp?id=547

 

The major factors driving the growth of the In-Vitro Diagnostic Market is increased patient awareness, patient self-testing, and increasing baby booming population across the globe. Advancement in the technology bringing more of automated tests is also one of the major drivers for the growth of IVD market.

 

The major players in the IVD market are Roche Diagnostics (Germany), Abbott Diagnostics (U.S.), Beckman Coulter (U.S.), BD Diagnostics (U.S.), and Siemens Diagnostics (Germany).

 

Browse Related Reports:

Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Application (Infectious Disease, Endocrinology, Cardiology, Oncology, Hematology), & End User - Global Forecast to 2019.

http://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html

 

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018.              

http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

 

About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

 

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

 

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

 

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

 

Contact:

Mr. Rohan

1 South Dearborn Street,

21st Floor, Chicago,

Illinois, 60603, United States,

Tel: +1-888-600-6441Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/pharmaceuticals

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets